Animal models with neuropathy have shown that mitigating NF-kB activation results in less severe damage to their brains; thus, confirming that targeting this signalling could be a useful therapeutic approach for various conditions that affect our cognitive system [74]. Here, NFKB1 is linked to neuropathy.